Fabio
70 lines
3.0 KiB
Markdown
70 lines
3.0 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Pseudoephedrine; require manufacturers to pay fees to National Association of Drug Diversion Investigators to support NPLE."
|
||
description: "Pseudoephedrine; require manufacturers to pay fees to National Association of Drug Diversion Investigators to support NPLE."
|
||
jurisdiction: "us/states/ms"
|
||
legislature: "Mississippi Legislature"
|
||
session: "2025"
|
||
identifier: "HB 1463"
|
||
citation: "Mississippi HB 1463 (2025)"
|
||
classification: ["bill"]
|
||
subjects: ["Drug Policy", "Public Health and Welfare"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Bell"]
|
||
version_count: 3
|
||
action_count: 12
|
||
vote_count: 2
|
||
first_action: "2025-01-20T06:00:00+00:00"
|
||
last_action: "2025-03-18T05:00:00+00:00"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/ee427674-a61b-4d43-bedb-5c1058b39e12"
|
||
source_url: "http://billstatus.ls.state.ms.us/2025/pdf/House_authors/Bell_(65th).xml"
|
||
source_hash: "8054d14e006251937377e321b6bb860bc9501e3714b5aaf1fd6ac4ebb9d6a372"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-ms"]
|
||
---
|
||
|
||
# Mississippi HB 1463 (2025) — Pseudoephedrine; require manufacturers to pay fees to National Association of Drug Diversion Investigators to support NPLE.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **As Introduced** (filed) — [source](http://billstatus.ls.state.ms.us/documents/2025/html/HB/1400-1499/HB1463IN.htm)
|
||
2. **As Passed the lower** (committee substitute) — [source](http://billstatus.ls.state.ms.us/documents/2025/html/HB/1400-1499/HB1463PS.htm)
|
||
3. **Current version** (committee substitute) — [source](http://billstatus.ls.state.ms.us/documents/2025/html/HB/1400-1499/HB1463SG.htm)
|
||
|
||
## Votes
|
||
|
||
- Passage — **118–0** (pass) · lower
|
||
- Passage — **50–1** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Bell — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2025-01-20T06:00:00+00:00** Referred To Drug Policy `referral-committee`
|
||
- **2025-01-30T06:00:00+00:00** Title Suff Do Pass `committee-passage`
|
||
- **2025-02-12T06:00:00+00:00** Read the Third Time `reading-3`
|
||
- **2025-02-13T06:00:00+00:00** Passed `passage`
|
||
- **2025-02-14T06:00:00+00:00** Transmitted To Senate `introduction`
|
||
- **2025-02-17T06:00:00+00:00** Referred To Public Health and Welfare `referral-committee`
|
||
- **2025-03-03T06:00:00+00:00** Title Suff Do Pass `committee-passage`
|
||
- **2025-03-11T05:00:00+00:00** Passed `passage`
|
||
- **2025-03-12T05:00:00+00:00** Returned For Enrolling
|
||
- **2025-03-13T05:00:00+00:00** Enrolled Bill Signed
|
||
- **2025-03-13T05:00:00+00:00** Enrolled Bill Signed
|
||
- **2025-03-18T05:00:00+00:00** Approved by Governor `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/ee427674-a61b-4d43-bedb-5c1058b39e12`. Confidence: reported (aggregated from official Mississippi legislature records).
|
||
|